US09075F3055 - Common Stock
In the largest study to date of bone and soft tissue tumors, OGM detected 100% of the variants found by multiple standard techniques, including...
BNGO earnings call for the period ending September 30, 2024.
Bionano Reports Third Quarter 2024 Results and Highlights Recent Business Progress...
Bionano to Report Third Quarter 2024 Financial Results and Host a Conference Call and Webcast on November 13, 2024...
SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered...
Special Meeting of Stockholders Adjourned Due to Lack of Quorum...
SAN DIEGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced select preliminary results for the quarter ended...
BNGO earnings call for the period ending June 30, 2024.
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the second quarter of ...
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress...
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief...
Three quantum AI stocks could shape the future of computing, which means current market prices are very cheap.
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants...
$10 million upfront with up to an additional $20 million upon the exercise in full of clinical milestone-linked Series Warrants...
A sponsored session will feature Dr. Lucia Gallego Villarejo from Ruhr University Bochum, Dr. Jeanne Loring from Scripps Research Institute, and Dr. Alicia...
Bionano announces software marketing agreement with Revvity for newborn sequencing research workflow....
Steer clear of these three companies facing significant challenges. Discover why these are risky healthcare stocks to sell.
Healthcare firms can make large amounts of money, particularly in the U.S. Here are the three best healthcare stocks to buy now.
BNGO stock results show that Bionano Genomics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the first quarter of 2...
BNGO earnings call for the period ending March 31, 2024.
Q1 2024 revenue was $8.8 million, which represents an 18% increase over Q1 2023Total installed base of 347 optical genome mapping (OGM) systems as of Q1...
A combination of nervous investors and highly aggressive short sellers has made many contrarian investments quite attractive.
Researchers used optical genome mapping in addition to whole genome sequencing in pediatric leukemia samples and identified additional structural...
Bionano Announces $10 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules...
A peer-reviewed study compared optical genome mapping (OGM) to classical cytogenetic techniques used for analysis of solid tumor cancer samples. ...
Bionano will host a pre-conference scientific session that will include a live product demonstration of the Stratys™ system for high throughput optical...
BNGO earnings call for the period ending December 31, 2023.
BNGO stock results show that Bionano Genomics missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bionano Genomics (NASDAQ:BNGO) just reported results for the fourth quarter of ...
Q4 2023 revenue was $10.7 million, which represents a 30% increase over Q4 2022FY 2023 revenue was $36.1 million, which represents a 30% increase over FY...
SAN DIEGO, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief...